Mexico - Delayed Quote MXN
Atossa Therapeutics, Inc. (ATOS.MX)
15.50
+2.50
+(19.23%)
At close: 12:18:44 PM CST
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-21,030
-21,030
--
-20,760
-16,472
Investing Cash Flow
-19
-19
--
-4,727
-9
Financing Cash Flow
3,673
3,673
--
--
113,304
End Cash Position
71,194
71,194
--
111,000
136,487
Capital Expenditure
-19
-19
--
-27
-9
Issuance of Capital Stock
--
--
--
--
69,668
Free Cash Flow
-21,049
-21,049
--
-20,787
-16,481
12/31/2021 - 11/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GNFT Genfit S.A.
3.6700
-2.65%
FBRX Forte Biosciences, Inc.
6.96
+15.04%
ENVB Enveric Biosciences, Inc.
1.3348
+3.47%
KALA KALA BIO, Inc.
3.3000
+5.77%
BLUE bluebird bio, Inc.
4.1600
+1.71%
PHIO Phio Pharmaceuticals Corp.
2.2300
+9.31%
CAPR Capricor Therapeutics, Inc.
13.28
+0.99%
VXRT Vaxart, Inc.
0.3600
+4.74%
INO Inovio Pharmaceuticals, Inc.
1.9200
+2.67%
PSTV Plus Therapeutics, Inc.
0.8427
-14.32%